CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 years Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey Non-obstructive High-Risk Plaques Increase the Risk of Future Culprit Lesions Comparable to Obstructive Plaques Without High-Risk Features: The ICONIC Study Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction Five-Year Outcomes with PCI Guided by Fractional Flow Reserve Right ventricular function and outcome in patients undergoing transcatheter aortic valve replacement

Clinical Trial2019 Sep 2.

JOURNAL:Eur J Heart Fail. Article Link

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 years

Iung B, Armoiry X, MITRA-FR Investigators. Keywords: severe secondary mitral regurgitation; TMVR+medical therapy vs medical thereapy alone; outcome

FULL TEXT PDF